JP2008525427A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525427A5
JP2008525427A5 JP2007547787A JP2007547787A JP2008525427A5 JP 2008525427 A5 JP2008525427 A5 JP 2008525427A5 JP 2007547787 A JP2007547787 A JP 2007547787A JP 2007547787 A JP2007547787 A JP 2007547787A JP 2008525427 A5 JP2008525427 A5 JP 2008525427A5
Authority
JP
Japan
Prior art keywords
nik
agent
binding
amino acids
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007547787A
Other languages
English (en)
Japanese (ja)
Other versions
JP5686940B2 (ja
JP2008525427A (ja
Filing date
Publication date
Priority claimed from IL16600604A external-priority patent/IL166006A0/xx
Application filed filed Critical
Publication of JP2008525427A publication Critical patent/JP2008525427A/ja
Publication of JP2008525427A5 publication Critical patent/JP2008525427A5/ja
Application granted granted Critical
Publication of JP5686940B2 publication Critical patent/JP5686940B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007547787A 2004-12-27 2005-12-11 NF−κB活性と関連する疾患を治療するための医薬組成物 Expired - Fee Related JP5686940B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL16600604A IL166006A0 (en) 2004-12-27 2004-12-27 Pharmaceutical compositions for treating diseases associated with nf-kb activity
IL166006 2004-12-27
PCT/IL2005/001335 WO2006070348A1 (en) 2004-12-27 2005-12-11 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY

Publications (3)

Publication Number Publication Date
JP2008525427A JP2008525427A (ja) 2008-07-17
JP2008525427A5 true JP2008525427A5 (enExample) 2009-01-29
JP5686940B2 JP5686940B2 (ja) 2015-03-18

Family

ID=36072106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007547787A Expired - Fee Related JP5686940B2 (ja) 2004-12-27 2005-12-11 NF−κB活性と関連する疾患を治療するための医薬組成物

Country Status (9)

Country Link
US (1) US8338567B2 (enExample)
EP (1) EP1838347B1 (enExample)
JP (1) JP5686940B2 (enExample)
AU (1) AU2005320905B2 (enExample)
CA (1) CA2593035C (enExample)
ES (1) ES2518340T3 (enExample)
IL (2) IL166006A0 (enExample)
NO (1) NO20073942L (enExample)
WO (1) WO2006070348A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5954728B2 (ja) 2010-01-22 2016-07-20 国立研究開発法人科学技術振興機構 蛋白質の分解活性を測定するためのプローブ試薬
EP3431493A1 (en) * 2013-09-03 2019-01-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for inducing senescence in cancer
WO2018085208A1 (en) 2016-11-02 2018-05-11 The Research Foundation For The State University Of New York Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US5843721A (en) 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
US6265538B1 (en) * 1998-02-27 2001-07-24 The Regents Of The University Of California Inhibitor of the inflammatory response induced by the TNFA and IL-1
ITMI20010402U1 (it) 2001-07-18 2003-01-18 Valerio Leccacorvi Rivestimento per le superfici di una piscina
ATE521707T1 (de) * 2002-04-18 2011-09-15 Yeda Res & Dev Derivate eines nf-kappab induzierenden enzyms, verfahren zur herstellung der derivate und deren verwendung

Similar Documents

Publication Publication Date Title
Madden et al. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
Mitrea et al. Disorder-function relationships for the cell cycle regulatory proteins p21 and p27
Argiolas Neuropeptides and sexual behaviour
EP2061886B1 (en) Small cationic immunomodulatory peptides
JP2018171063A5 (enExample)
Rai Peptide and protein mimetics by retro and retroinverso analogs
JP2004536614A5 (enExample)
JP2007529204A5 (enExample)
CN101264326A (zh) 阿尔茨海默氏病的治疗方法
JP2011502964A5 (enExample)
JP2018509935A5 (enExample)
JP2017524382A5 (enExample)
JP2000312590A5 (enExample)
JP2019525753A5 (enExample)
JP2013513377A5 (enExample)
WO2006090810A3 (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
JP2016527891A5 (enExample)
JP2002505841A5 (enExample)
ATE369440T1 (de) Rationale auswahl von mutmasslichen peptiden aus identifizierten nukleotid- beziehungsweise peptidsequenzen
JP2019531716A5 (enExample)
EA201790341A1 (ru) Анти-ск8 антитела для применения в лечении рака
JP2017528129A5 (enExample)
JP2008525427A5 (enExample)
JP2020500150A5 (enExample)
Chen et al. Development of membrane‐active peptide therapeutics in oncology